QUINTESSENTIAL-2

Phase 3 Clinical Trial Comparing the Safety and Efficacy of BMS-986393 to Standard of Care Regimens in Patients with Relapsed/Refractory Multiple Myeloma

Near Add Your Location

Sorting 19 by

Chao Family Comprehensive Cancer Center
University of California, Irvine
Orange, CA
  • Accepting patients
Fox Chase Cancer Center
Temple Health
Philadelphia, PA
  • Accepting patients
University of Alabama at Birmingham
O'Neal Comprehensive Cancer Center
Birmingham, AL
  • Accepting patients
Stony Brook University Hospital
Stony Brook, NY
  • Not yet accepting
Boston Medical Center
Boston, MA
  • Accepting patients
Ochsner LSU Health Shreveport
Ochsner Louisiana State University
Shreveport, LA
  • Accepting patients
Sylvester Comprehensive Cancer Center (Main)
University of Miami Health System
Miami, FL
  • Accepting patients
Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 354-2873

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.